Abstract
BackgroundNasal high flow delivered at flow rates higher than 60 L/min in patients with acute hypoxemic respiratory failure might be associated with improved physiological effects. However, poor comfort might limit feasibility of its clinical use.MethodsWe performed a prospective randomized cross-over physiological study on 12 ICU patients with acute hypoxemic respiratory failure. Patients underwent three steps at the following gas flow: 0.5 L/kg PBW/min, 1 L/kg PBW/min, and 1.5 L/kg PBW/min in random order for 20 min. Temperature and FiO2 remained unchanged. Toward the end of each phase, we collected arterial blood gases, lung volumes, and regional distribution of ventilation assessed by electrical impedance tomography (EIT), and comfort.ResultsIn five patients, the etiology was pulmonary; infective disease characterized seven patients; median PaO2/FiO2 at enrollment was 213 [IQR 136–232]. The range of flow rate during NHF 1.5 was 75–120 L/min. PaO2/FiO2 increased with flow, albeit non significantly (p = 0.064), PaCO2 and arterial pH remained stable (p = 0.108 and p = 0.105). Respiratory rate decreased at higher flow rates (p = 0.014). Inhomogeneity of ventilation decreased significantly at higher flows (p = 0.004) and lung volume at end-expiration significantly increased (p = 0.007), but mostly in the non-dependent regions. Comfort was significantly poorer during the step performed at the highest flow (p < 0.001).ConclusionsNHF delivered at rates higher than 60 L/min in critically ill patients with acute hypoxemic respiratory failure is associated with reduced respiratory rate, increased lung homogeneity, and additional positive pressure effect, but also with worse comfort.
Highlights
Nasal high flow delivered at flow rates higher than 60 L/min in patients with acute hypoxemic respiratory failure might be associated with improved physiological effects
We reasoned that Nasal high flow (NHF) delivered at flow rates higher than 60 L/min in acute hypoxemic respiratory failure (AHRF) patients might be associated with positive physiological effects improving lung protection and potentially decreasing the risk of failure in comparison to current clinically used flow rates
Data collection At enrolment, the following variables were collected: sex, age, body mass index (BMI), predicted body weight (PBW), Sepsis-related Organ Failure Assessment (SOFA) score, Simplified Acute Physiology Score (SAPS) Simplified acute physiology score II (II), and PaO2/FiO2 at intensive care unit (ICU) admission, etiology, and number of quadrants involved on chest X-ray
Summary
Nasal high flow delivered at flow rates higher than 60 L/min in patients with acute hypoxemic respiratory failure might be associated with improved physiological effects. Nasal high flow (NHF) delivers heated and humidified air/oxygen mixture through specific prongs [8] Previous studies showed both the physiological and clinical benefits of noninvasive support by NHF in AHRF patients [9, 10], to the point that NHF can already be considered as the recommended first-line noninvasive approach [11,12,13]. We reasoned that NHF delivered at flow rates higher than 60 L/min in AHRF patients might be associated with positive physiological effects improving lung protection and potentially decreasing the risk of failure in comparison to current clinically used flow rates. We assessed comfort at these very high flow rates, as patient tolerance is a key factor for the clinical success of NHF
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
